We are live on ! Find out more
HRMY icon

Harmony Biosciences

146 hedge funds and large institutions have $1.9B invested in Harmony Biosciences in 2021 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 39 increasing their positions, 30 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

286% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 14

71% more capital inflows, than outflows

Capital inflows: $232M | Capital outflows: $136M

43% more funds holding

Funds holding: 102 → 146 (+44)

33% more funds holding in top 10

Funds holding in top 10: 6 → 8 (+2)

30% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 30

21.95% more ownership

Funds ownership: 54.26% → 76.21% (+22%)

Holders
146
Holders Change
+44
Holders Change %
+43.14%
% of All Funds
2.24%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.12%
New
54
Increased
39
Reduced
30
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

HRMY Hedge Fund Activity: Q4 2021 in Review

146 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Harmony Biosciences (HRMY) for Q4 2021, worth a combined $1.9B — up 60% from $1.19B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new HRMY positions and 14 closed out — a net gain of 40 holders — while 39 added to existing stakes and 30 trimmed.

The largest buyer was BlackRock, adding an estimated $84.7M. The largest seller was Newlight Partners, cutting an estimated $39.9M.

  • 146 institutional investors held Harmony Biosciences (HRMY) as of Q4 2021, up from 102 in Q3 2021.
  • Funds reported $1.9B of Harmony Biosciences stock for Q4 2021, up 60% quarter-over-quarter.
  • 54 funds opened new Harmony Biosciences positions in Q4 2021 and 14 closed out, a net change of +40 holders.
  • The largest Harmony Biosciences buyer in Q4 2021 was BlackRock, an estimated $84.7M added.
  • The largest Harmony Biosciences seller in Q4 2021 was Newlight Partners, an estimated $39.9M sold.

Based on aggregated 13F filings for Q4 2021.